[1]Montano-Loza AJ. Muscle wasting: a nutritional criterion to prioritize patients for liver transplantation. Curr Opin Clin Nutr Metab Care,2014,17(3):219-225. [2]Kalafateli M, Konstantakis C, Thomopoulos K,et al. Impact of muscle wasting on survival in patients with liver cirrhosis. World J Gastroenterol,2015,21(24):7357-7361. [3]Montano–Loza AJ, Meza–Junco J, Prado CMM,et al. Muscle wasting is associated with mortality in patients with cirrhosis. Clin Gastroenterol Hepatol,2012,10(2):166-173. [4]Hanai T, Shiraki M, Ohnishi S,et al. Rapid skeletal muscle wasting predicts worse survival in patients with liver cirrhosis. Hepatol Res,2016,46(8):743-751. [5]Cederholm T, Barazzoni R, Austin P,et al. ESPEN guidelines on definitions and terminology of clinical nutrition. Clin Nutr,2016,36(1):49-64. [6]Rowland I, Gibson G, Heinken A,et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr,2018,57(1):1-24. [7]Yao J, Chang L, Yuan L,et al. Nutrition status and small intestinal bacterial overgrowth in patients with virus - related cirrhosis. Asia Pac J Clin Nutr,2016,25(2):283-291. [8]Qin N, Yang F, Li A,et al. Alterations of the human gut microbiome in liver cirrhosis. Nature,2014,513(7516):59-64. [9]Yao J, Zhou X, Yuan L,et al. Prognostic value of the third lumbar skeletal muscle mass index in patients with liver cirrhosis and ascites. Clin Nutr,2019,S0261-5614(19):33018-33023. [10]Nishikawa H, Shiraki M, Hiramatsu A,et al. Japan society of hepatology guidelines for sarcopenia in liver disease (1st edition): recommendation from the working group for creation of sarcopenia assessment criteria. Hepatol Res,2016,46(10):951-963. [11]Roat KJ, Pedro CL, Kristoffer F,et al. MOCAT2: a metagenomic assembly, annotation and profiling framework. Bioinformatics,2016,32(16):2520-2523. [12]周永健. 肠道微生态与肝硬化. 实用肝脏病杂志,2016,19(2):139-142. [13]Maharshi S, Sharma BC, Srivastava S. Malnutrition in cirrhosis increases morbidity and mortality. J Gastroen Hepatol,2015,30(10):1507-1513. [14]Chen Y, Yang F, Lu H,et al. Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology,2011,54(2):562-572. [15]Tilg H, Cani PD, Mayer EA. Gut microbiome and liver diseases. Gut,2016,65(12):2035-2044. [16]Barko PC, McMichaelMA, Swanson KS,et al. The gastrointestinal microbiome: a review. J Vet Intern Med,2018,32(1):9-25. [17]Clarke SF, Murphy EF, O'Sullivan O,et al. Exercise and associated dietary extremes impact on gut microbial diversity. Gut,2014,63(12):1913-1920. [18]Gosalbes MJ, Durbán A, Pignatelli M,et al. Metatranscriptomic approach to analyze the functional human gut microbiota. Plos One,2011,6(3):e17447. [19]Pieter VDA, Belzer C, Goossens M,et al. Butyrate-producing clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. Isme J,2013,7(5):949-961. [20]Meehan CJ, Beiko RG. A phylogenomic view of ecological specialization in the lachnospiraceae, a family of digestive tract-associated bacteria. Genome Biol Evol,2014,6(3):703-713. [21]Benítez Páez A, Gómez Del Pulgar EM, Sanz Y. The glycolytic versatility of bacteroides uniformis CECT 7771 and its genome response to oligo and polysaccharides. Front Cell Infect Microbiol,2017,7(7):383. [22]Wexler HM. Bacteroides: the good, the bad, and the nitty-gritty. Clin Microbiol Rev,2007,20(4):593-621. [23]Flint HJ, Scott KP, Duncan SH,et al. Microbial degradation of complex carbohydrates in the gut. Gut Microbes,2012,3(4):289-306. |